Immediate Impact
3 from Science/Nature 53 standout
Citing Papers
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
2025 Standout
Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy
2024 Standout
Works of Sarah M. Larson being referenced
CD19/CD20 bispecific chimeric antigen receptor (CAR) in naïve/memory T cells for the treatment of relapsed or refractory non-Hodgkin lymphoma.
2022
Pre-clinical development of gene modification of haematopoietic stem cells with chimeric antigen receptors for cancer immunotherapy
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Sarah M. Larson | 252 | 334 | 194 | 197 | 69 | 724 | |
| Hwa Jung Sung | 142 | 211 | 130 | 148 | 70 | 644 | |
| G. J. Ossenkoppele | 300 | 305 | 133 | 268 | 51 | 817 | |
| Vincenzo Pitini | 180 | 230 | 189 | 131 | 48 | 716 | |
| Giuseppina Massini | 169 | 290 | 155 | 339 | 39 | 786 | |
| Stéphanie Harel | 305 | 178 | 267 | 107 | 50 | 745 | |
| Dimitra Anagnostou | 176 | 162 | 247 | 300 | 39 | 678 | |
| Claudiu Cotta | 182 | 133 | 122 | 121 | 49 | 623 | |
| Leonard M. Klein | 202 | 426 | 230 | 220 | 48 | 821 | |
| Eulogio Conde | 182 | 402 | 177 | 522 | 43 | 849 | |
| Uma Borate | 462 | 234 | 166 | 123 | 83 | 796 |
All Works
Login with ORCID to disown or claim papers
Loading papers...